On June 10, 2026, Chae Kyu-han, Deputy Director General for Narcotics Safety Planning at the Ministry of Food and Drug Safety, accompanied by a delegation, visited Neocannbio’s production center in An..

Neocannbio participated in the 2026 Seoul K-Bio Week: Green Bio Future Strategy Forum, held at the Korea Press Center on June 8, 2026. Minister of Agriculture, Food and Rural Affairs Song Mi-ryung vis..

On May 21, 2026, Yang Kwang-seok, Director General of the Bureau of Special Economic Zones Innovation Planning at the Ministry of SMEs and Startups, visited Neocannbio’s production center in Andong al..

❍ Topic : Reporting 2026 YTD business status and key annual plans❍ Date : 2026. 5. 6. (Wed) 15:00❍ Location : Seoul Bio Hub Global Center 1F Seminar Room G11❍ Attendees : 11 institutional investors of..

On February 23, 2026, Neocannbio participated in the "Policy Forum on Hemp Regulatory Reform for the Global Leap of the Hemp Industry", co-hosted by the Offices of National Assembly Members, Gyeongsan..

On January 22, 2026, Neocannbio signed an agreement with Oz Medicann Group, an Australian medical hemp specialist, in Sydney, Australia, for the supply of medical hemp raw materials and joint clinical..

Neocannbio held the 1st Korea-Japan Medical Hemp International Conference at Andong Stanford Hotel on December 17th, 2025. The conference featured speakers representing the current Japanese hemp indus..

On December 17, 2025, Neocannbio held a groundbreaking ceremony for Korea's first hemp-derived Active Pharmaceutical Ingredients GMP Plant in Pungsan-myeon, Andong-si, on land owned by Neocannbio. The..

❍ Topic : Reporting 2025 H2 results and 2026 business plan ❍ Date : 2025. 12. 17. (Wed) 10:30 ❍ Location : Main Conference Room, Gyeongbuk Insitute for Bio industry❍ Attendees : 11 institutional inves..

Neocannbio participated in the Japan International Hemp Expo (JIHE) 2025 held in Japan with NeoShyne, a joint venture established in the United States.During the Exop period between November 14, 2025 ..